US FDA approves Pfizer-OPKO’s drug for growth hormone deficiency in kids, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

The approval for the drug, which comes after an initial rejection from the FDA in January last year, lifted Pfizer’s shares marginally and Opko Health over 27% in premarket trading., The approval for the drug, which comes after an initial rejection from the FDA in January last year, lifted Pfizer’s shares marginally and Opko Health over 27% in premarket trading., , Read More